ChargePoint Technology and STERIS collaborate to offer fully validated sterile transfer solution

Sterile transfer solutions without compromising operational efficiency.

Integrating ChargePoint’s AseptiSafe Bio Transfer Valve with the STERIS VHP Biodecontamination Systems provides users with a fully validated solution for the sterile transfer of drug substances and drug products during biopharmaceutical manufacturing.

As regulations around sterile/aseptic processing continue to expand, many manufacturers are looking for sterile transfer solutions that do not compromise operational efficiency.

The ChargePoint split butterfly valve (SBV) technology enables contained transfers into a manufacturing process, providing sterility assurance during aseptic processing. The technology reduces the need for operator intervention and for cleaning and validating large areas which, in turn, minimizes downtime and improves efficiencies during manufacturing.

Christian Dunne, head of sterile solutions at ChargePoint Technology, said: “Combining expertise from the two teams ensures that we are able to offer customers across the globe a unique and efficient solution to one of today’s drug manufacturing challenges.”

The AseptiSafe Bio Transfer Valve uses an enhanced decontamination step, exposing the SBV discs to vaporized hydrogen peroxide (VHP) gas within a sealed chamber. This provides a validated 6-log reduction in bioburden during the drug substance transfer process and removes the need for high-grade cleanroom environments around the process.

The STERIS VHP generators provide an all-in-one system unit for biodecontamination in medical, biological and pharmaceutical facilities. The generators utilise STERIS Vaprox Hydrogen Peroxide Sterilant to achieve dry, low-temperature biodecontamination within sealed enclosures for maximum biodecontamination.